Skip to content

NMIN

EVENTS

Vancouver Nanomedicine Day 2023

November 15, 2023 

NMIN

PHOTO GALLERY

Hover over the image to access forward / backward slideshow options

Nanomedicine Day 2023

NMIN

VIDEO GALLERY

Recordings of most sessions from the event are available below.

Welcome to the 8th Vancouver Nanomedicine Day

Urs Häfeli

University of British Columbia

Organizer, Vancouver Nanomedicine Day 2023

Single-molecule & single-cell microscopy of mRNA LNPs

Sabrina Leslie

University of British Columbia

Induction of Bleb Structures in LNP Formulations of mRNA

Miffy Cheng

University of British Columbia

Semiconducting Polymer Dots Directly Stabilized with Serum Albumin

Yihao Wang

University of British Columbia

Site Specific Immunomodulators: An Innately Novel Approach for the Prevention & Treatment of Chronic Inflammatory Diseases & Cancer

Shirin Kalyan

Qu Biologics

Self-assembling nanostructure-enhanced sublingual delivery of protein drugs

Jiamin Wu

University of British Columbia

An Introduction to the NanoMedicines Innovation Network (NMIN)

Diana Royce

NMIN

KEYNOTE: What is the Future of Nanomedicines?

Pieter Cullis

University of British Columbia

Nanomedicines for Gene Therapy: Optimization of LNPs for Therapeutic Genome Editing

Colin Ross

University of British Columbia

Dual Functionalization of Iron Oxide Nanoparticles

Melissa Radford

Simon Fraser University

Aptamer Conjugated nanoparticles for Tumor Imaging

Lennart Bohrmann

University Hospital Basel, Switzerland

DNA Nano-Cubes as Highly Tunable Scaffold for Biosensors Engineering

Adrian Grzedowski

University of British Columbia

Innovation Headroom for a More Accurate PD-L1 Companion Diagnostic

Nick Dragojlovic

University of British Columbia

A Novel Liposomal Irinotecan Formulation Is a Potent Immunogenic Cell Death Inducer

XuXin Sun

BC Cancer Research | University of British Columbia

Development of Pegylated Liposomal Amphotericin B

Virginia Vallejos

Federal University of Minas Gerais (UFMG), Brazil

Directing the Biointerface of Polyelectrolyte Nanocomplexes to Treat Bacterial Biofilm Infections

Joel Finbloom

University of British Columbia

Engineering Polymers for Resuscitation of Trauma Patients

Ethan Mickelson

University of Washington

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta

Hannah Safford

University of Pennsylvania

Comprehensive mRNA-LNP Characterization using Single-Cell Techniques

Abishek Wadhwa

University of British Columbia

NMIN

About

This world-class symposium, the eighth event of its kind, will gather renowned Canadian and international experts from across the nanomedicines field to:

  • highlight the discoveries and innovations in nanomedicines that are contributing to global progress in acute, chronic and orphan disease treatment and management;
  • present up-to-date diagnostic and therapeutic  nanomedicine approaches to addressing the challenges of COVID-19; and
  • facilitate discussion among nanomedicine researchers and innovators and UBC and NMIN clinician-scientists, basic researchers, trainees, and research partners.

Vancouver Nanomedicine Day 2023 is an in-person local event, taking place in Auditoriums 1101 & 1201 of the Pharmaceutical Sciences Building on the campus of the University of British Columbia in Vancouver, BC. However, we plan to record the talks and make them available afterwards on this webpage.

Since 2014, a cluster of researchers at the University of British Columbia (UBC) has organized Vancouver Nanomedicine Day to advance nanomedicine research, knowledge mobilization and commercialization in Canada by sharing high-impact findings and facilitating interaction—among researchers, postdoctoral fellows, graduate students, and life science and startup biotechnology companies—to catalyze research collaboration.

Organizer:

Dr. Urs Häfeli, PhD, Professor of Pharmaceutical Sciences at the University of British Colombia

urs.hafeli@ubc.ca

 

Organizer:

Dr. Urs Häfeli, PhD, Professor of Pharmaceutical Sciences at the University of British Colombia

urs.hafeli@ubc.ca

 

Nanomedicine is an interdisciplinary research area within nanotechnology that aims to develop medical technologies at the nanoscale, ranging from drug delivery carriers and imaging agents to nanomaterials and nanoelectronic biosensors.

NMIN

PROGRAM

Vancouver Nanomedicine Day 2023 will feature:

  • A keynote address by Pieter Cullis, who will present to us his vision of where the nanomedicine revolution will lead us
  • Invited talks, including by internationally renowned experts in the field of gene therapy, lipid nanoparticle analysis, optimization and therapeutic application, as well as immunotherapy and nanotoxicology
  • Presentations by other leading experts from the local and national nanomedicine field will show the breadth and diversity of the research going on in Vancouver and Canada
  • A poster session highlighting the ongoing and most up-to-date research in all fields of nanomedicine

NOTE that all times in the program are in Pacific Daylight Time (PDT).

Featured speakers

Aptamer Conjugated Nanoparticles for Cancer Targeting: In Vitro and In Vivo Evaluation

Lennart Bohrmann, University Hospital Basel (Switzerland)

What is the Future of Nanomedicines?

Pieter Cullis, University of British Columbia

Site Specific Immunomodulators – An Innately Novel Approach for the Prevention and Treatment of Chronic Inflammatory Diseases and Cancer

Shirin Kalyan, Qu Biologics Inc.

Single-Particle & Single-Cell Imaging to Quantitate Biophysical Properties of mRNA Lipid Nanoparticles & Engineer Improved Vaccines & Therapies

Sabrina Leslie, University of British Columbia

Nanomedicines for Gene Therapy: Optimization of Lipid Nanoparticles for Therapeutic Genome Editing

Colin Ross, University of British Columbia

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta

Hannah Safford, University of Pennsylvania (USA)

NMIN

REGISTRATION

Registration to the in-person Vancouver Nanomedicine Day 2023 is free. However, your advance registration is required for planning purposes.

We look forward to including you on November 15, 2023!

Registration for this event is now closed.

NO PARTICIPATION LINK?
Did you register for this event without ever receiving a participation link by email?

Please register by September 4, 2019

NMIN

posterS

Congratulations to the winners of the Vancouver Nanomedicine Day 2023 poster competition.

The winning posters were:

 
 
3rd place: Safety of Genome Editing: Development of a Fluorescent Model System to Inves/gate Reducing Off-Target Genome Edits by Base Editors, by Tessa Morin (Pharmacy, UBC)

L to R: Christine Traaseth (2nd place), Dinh Nguyen (1st place) and Tessa Morin (3rd place). Inset: poster competition organizer Abishek Wadhwa.

Congratulations to the winners of the Vancouver Nanomedicine Day 2023 poster competition.

The winning posters were:



3rd place: Safety of Genome Editing: Development of a Fluorescent Model System to Inves/gate Reducing Off-Target Genome Edits by Base Editors, by Tessa Morin (Pharmacy, UBC)

The deadline for the submission of abstracts to Vancouver Nanomedicine Day 2023 was October 1, 2023 at midnight (PDT).

From submitted abstracts, a committee has finalized the program. Some abstracts have been chosen as talks, others as posters.

The posters were exhibited for the entire day, and poster judges rated them.

There were 3 cash prizes, thanks to our sponsors.

The deadline for the submission of abstracts to this event has passed.

abstracts

Late abstracts will be accepted for consideration as posters.

Please submit your one-page abstract following this template.

  • Start with a figure or scheme (similar to a graphical abstract)
  • Use title capitalization for the title
  • List all authors with full first and last names
  • Add the email of the corresponding author
  • Provide a precise abstract including some data

The deadline for the submission of abstracts to this event has passed.

To submit, click on the “submit your abstract” button, complete the online form, and upload your one-page PDF.

Late abstracts will be accepted for consideration as posters

NMIN

venue

This event took place in the Pharmaceutical Sciences building, 2405 Wesbrook Mall, on the campus of the University of British Columbia (UBC) in Vancouver, BC, Canada.

Presentations were given in Auditorium 1101, with overflow in Auditorium 1201.

Searchable UBC campus map

 

Opened in 2012, the Pharmaceutical Sciences building at UBC is a state-of-the-art learning and research facility. Measuring 246,000 square feet, it’s eye-catching and has drawn attention and admiration from around the world—including 15 awards of excellence. Leading the way in sustainable construction, this forward-thinking structure was made possible by an $86.4-million investment from the Province of BC and the generous support of donors, including many UBC alumni.

 

NMIN

sponsors

tHANKS TO OUR SPONSORS

GOLD

Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.

The NanoMedicines Innovation Network (NMIN) is a federally-funded national research network that brings investigators from universities across Canada together with industry and public sector partners to expand and improve Canada’s position as world leader in nanomedicines R&D.

The Faculty's vision - as innovators in pharmacy education, research and practice - is to support the optimization of drug therapy in the pursuit of improved patient outcomes.

SILVER

PNI is a global leader in technology and solutions for developing RNA, DNA, CRISPR, small molecule drugs, COVID vaccines and therapeutics rapidly taking ideas to patients.

Uniquely operated in British Columbia as an independent CRO, BRI focuses on pre-clinical and clinical programs supporting biotech and pharmaceutical companies. BRI has capabilities in LC/MS/MS and multiplex ELISA bioanalytical, in-vivo and in-vitro drug metabolism, pharmacokinetics and human tumor xenograft mouse models.

Malvern Panalytical provides analytical systems and solutions which enable complex biophysical profiles to be characterized. Our approach includes a range of orthogonal and complementary analytical techniques along with consultation and applications expertise.

STEMCELL Technologies Inc. supports global life sciences research with more than 2,500 specialized tools and services. They provide high quality cell culture media, cell separation technologies, instruments, accessory products and scientific services that are used by scientists conducting stem cell biology, immunology, cancer, regenerative medicine, and cellular therapy research.

NanoVation Therapeutics (NVT) is an early-stage gene therapy company focused on developing personalised therapeutics to treat age-related conditions using lipid nanoparticle and nucleic acid-based technologies. NVT develops next-generation platform technologies to enable efficient extrahepatic gene therapy and is available for partnering opportunities.

Sponsor advertisement

Sponsor advertisement